Literature DB >> 20386534

Reversible cardiotoxicity with tyrosine kinase inhibitors.

Jawad Francis1, Manmeet S Ahluwalia, Meir Wetzler, Eunice Wang, Pamela Paplham, Shannon Smiley, Philip L McCarthy, I Larry Cohen, Edward Spangenthal, Minoo Battiwalla.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20386534

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN： 1543-0790


× No keyword cloud information.
  2 in total

1.  Adaptation of Human iPSC-Derived Cardiomyocytes to Tyrosine Kinase Inhibitors Reduces Acute Cardiotoxicity via Metabolic Reprogramming.

Authors:  Huan Wang; Robert P Sheehan; Adam C Palmer; Robert A Everley; Sarah A Boswell; Noga Ron-Harel; Alison E Ringel; Kristina M Holton; Connor A Jacobson; Alison R Erickson; Laura Maliszewski; Marcia C Haigis; Peter K Sorger
Journal:  Cell Syst       Date:  2019-05-08       Impact factor: 10.304

2.  Reversible ventricular arrythmia induced by dasatinib.

Authors:  Hervé Spechbach; Philippe Morel; Kuntheavy Ing Lorenzini; Marie Besson; Laurent Gétaz; Henri Sunthorn; Yves Chalandon
Journal:  Clin Case Rep       Date:  2013-07-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.